Most recently, Shen et al. [145] tested coating solid lipid nanoparticles with hyaluronan (HA-SLNs) for targeted delivery of paclitaxel (PTX) to CD44-overexpressing B16F10 melanoma cells. This evidence concerns the gene CD44 and melanoma.